Susan ALTSCHULLER is a director of Mural Oncology plc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Cerevel Therapeutics Holdings, Inc.
23 Jan 24
4
Cerevel Therapeutics Holdings, Inc.
21 Dec 23
4
Mural Oncology plc
18 Dec 23
3
Mural Oncology plc
7 Nov 23
4
Cerevel Therapeutics Holdings, Inc.
5 Jun 23
3
Cerevel Therapeutics Holdings, Inc.
19 May 23
144
ImmunoGen, Inc.
5 May 23
4
ImmunoGen, Inc.
27 Dec 22
4
ImmunoGen, Inc.
8 Feb 22
4
ImmunoGen, Inc.
9 Feb 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
19 Jan 24 | CERE Cerevel Therapeutics | RSU Common Stock | Grant | Acquire A | No | No | 0 | 81,065 | 0.00 | 81,065 |
20 Dec 23 | CERE Cerevel Therapeutics | Common Stock | Sell | Dispose S | No | No | 41.4232 | 13,808 | 571.97 k | 16,913 |
19 Dec 23 | CERE Cerevel Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 30,721 | 0.00 | 30,721 |
19 Dec 23 | CERE Cerevel Therapeutics | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 30,721 | 0.00 | 0 |
14 Dec 23 | MURA Mural Oncology | Stock Option Ordinary Shares | Grant | Acquire A | No | No | 3.61 | 15,021 | 54.23 k | 15,021 |
1 Jun 23 | CERE Cerevel Therapeutics | RSU Common Stock | Grant | Acquire A | No | No | 0 | 30,721 | 0.00 | 30,721 |
1 Jun 23 | CERE Cerevel Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 32.55 | 124,168 | 4.04 mm | 124,168 |